CASTLE BIOSCIENCES INC - Common Stock (CSTL)

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Equity / Common Stock
Shares outstanding
28.9M
Number of holders
151
Total 13F shares, excl. options
22.7M
Shares change
+1.3M
Total reported value, excl. options
$1.02B
Value change
+$59.5M
Put/Call ratio
0
Number of buys
89
Number of sells
-56
Price
$44.86

Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q1 2022

170 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q1 2022.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22.7M shares of 28.9M outstanding shares and own 78.64% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (3.44M shares), BlackRock Inc. (1.78M shares), VANGUARD GROUP INC (1.18M shares), ARK Investment Management LLC (1.17M shares), Invesco Ltd. (1.08M shares), Granahan Investment Management, LLC (794K shares), MACQUARIE GROUP LTD (659K shares), Point72 Asset Management, L.P. (623K shares), GW&K Investment Management, LLC (611K shares), and Bellevue Group AG (608K shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.